Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.468 EUR | 0.00% | -4.10% | +4.93% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Business Summary
Number of employees: 1
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -72.59% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -72.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bruno Rosen
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Bieneck
BRD | Director/Board Member | 56 | - |
Arne Segler
CHM | Chairman | - | - |
Director/Board Member | - | - | |
Sören Rose
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,137,498 | 2,099,049 ( 40.86 %) | 0 | 40.86 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+4.93% | 2.59M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- T5O Stock
- Company bioXXmed AG